Skip to main content

and
  1. Article

    Open Access

    Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial

    Patient decision aids (PtDAs) have been reported to have a positive influence on patients making a health care decision in trials. Nevertheless, post-trial implementation is poor. The aim of this study is to e...

    D. B. Raphael Daniela, N. S. Russell in Breast Cancer Research and Treatment (2021)

  2. No Access

    Article

    The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

    The large-scale genetic profiling of tumours can identify potentially actionable molecular variants for which approved anticancer drugs are available13. However, when patients with such variants are treated with...

    D. L. van der Velden, L. R. Hoes, H. van der Wijngaart in Nature (2019)

  3. Article

    Open Access

    Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib

    Poly (ADP-ribose) Polymerase (PARP) inhibitors are promising novel radiosensitisers. Pre-clinical models have demonstrated potent and tumour-specific radiosensitisation by PARP inhibitors. Olaparib is a PARP i...

    R. de Haan, E. van Werkhoven, M.M. van den Heuvel, H. M. U. Peulen in BMC Cancer (2019)

  4. Article

    Open Access

    The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes

    Hybrid image-guided surgery technologies such as combined radio- and fluorescence-guidance are increasingly gaining interest, but their added value still needs to be proven. In order to evaluate if and how flu...

    G. H. KleinJan, E. van Werkhoven in European Journal of Nuclear Medicine and M… (2018)

  5. No Access

    Article

    Phase I study of combined indomethacin and platinum-based chemotherapy to reduce platinum-induced fatty acids

    Chemotherapy-resistance remains a major obstacle to effective anti-cancer treatment. We previously showed that platinum analogs cause the release of two fatty acids. These platinum-induced fatty acids (PIFAs) ...

    Daphne L. van der Velden, Geert A. Cirkel in Cancer Chemotherapy and Pharmacology (2018)

  6. Article

    Open Access

    Short-term outcome after cystectomy: comparison of early oral feeding in an enhanced recovery protocol and feeding using Bengmark nasojejunal tube

    Cystectomy for bladder cancer is associated with a high risk of postoperative complications. Standardized perioperative protocols, such as enhanced recovery after surgery (ERAS) protocols, aim to improve posto...

    C. S. Voskuilen, E. E. Fransen van de Putte in World Journal of Urology (2018)

  7. No Access

    Article

    An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome

    Endoxifen concentrations have been associated with breast cancer recurrence in tamoxifen-treated patients. However, tamoxifen itself and other metabolites also show antiestrogenic anti-tumor activity. Therefor...

    A. H. M. de Vries Schultink, X. Alexi in Breast Cancer Research and Treatment (2017)

  8. No Access

    Article

    Quantification of patient-reported outcome measures of radiation-induced skin reactions for use in clinical trial design

    Skin toxicity is a common effect from radiotherapy, although difficult to predict on an individual basis, and there is little evidence-based management. This study aimed to quantify inter-patient variation in ...

    N. S. Russell, E. van Werkhoven, S. B. Schagen in Supportive Care in Cancer (2017)

  9. No Access

    Article

    The performance of model-based versus rule-based phase I clinical trials in oncology

    Phase I studies with anticancer drugs are used to evaluate safety and tolerability and to choose a recommended phase II dose (RP2D). Traditionally, phase I trial designs are rule-based, but for several years t...

    E. M. J. van Brummelen, A. D. R. Huitema in Journal of Pharmacokinetics and Pharmacody… (2016)

  10. No Access

    Article

    Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period

    The purpose of this study was to study the impact of changes in clinical practice on outcome in patients treated with breast-conserving therapy (BCT) over a period of 28 years. Patients with early invasive bre...

    S. C. J. Bosma, F. van der Leij, E. van Werkhoven in Breast Cancer Research and Treatment (2016)

  11. No Access

    Article

    The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure

    The Neoadjuvant response index (NRI) has been proposed as a simple measure of downstaging by neoadjuvant treatment in breast cancer. It was previously found to predict recurrence-free survival (RFS) in triple-...

    M. Jebbink, E. van Werkhoven, I. A. M. Mandjes in Breast Cancer Research and Treatment (2015)

  12. Article

    Open Access

    Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer

    Changing the neoadjuvant chemotherapy regimen in insufficiently responding breast cancer is not a standard policy. We analysed a series of patients with ‘luminal’-type breast cancer in whom the second half of ...

    L S Rigter, C E Loo, S C Linn, G S Sonke, E van Werkhoven in British Journal of Cancer (2013)

  13. No Access

    Article

    Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival

    To analyse whether the reported differences in nodal yield at pelvic lymph node dissection (PLND) for bladder cancer, between two hospitals, are reflected in the survival rates.

    L. S. Mertens, R. P. Meijer, E. van Werkhoven, A. Bex in World Journal of Urology (2013)

  14. No Access

    Article

    8 De waarde van echogeleide cytologische punctie in de follow-up van de liesklieren bij peniscarcinoom

    R.S. Djajadiningrat, H.J. Teertstra, E. van Werkhoven in Tijdschrift voor Urologie (2013)

  15. No Access

    Article

    19 Inductiechemotherapie en chirurgie bij klierpositief blaascarcinoom

    R.P. Meijer, L.S. Mertens, B.W. van Rhijn, A. Bex in Tijdschrift voor Urologie (2013)

  16. No Access

    Article

    Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

    The aim of this study was to evaluate the association of primary tumour 18F-fluorodeoxyglucose (FDG) uptake with clinical, histopathological and molecular characteristics of breast cancer patients scheduled for n...

    B. B. Koolen in European Journal of Nuclear Medicine and M… (2012)

  17. No Access

    Article

    Langetermijnoverleving bij peniscarcinoom; ervaring met 1000 opeenvolgende patiënten

    R.S. Djajadiningrat, N.M. Graafland, E. van Werkhoven in Tijdschrift voor Urologie (2012)